2bc4: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /><applet load="2bc4" size="450" color="white" frame="true" align="right" spinBox="true" caption="2bc4, resolution 2.270Å" /> '''Crystal structure o...
 
No edit summary
Line 1: Line 1:
[[Image:2bc4.gif|left|200px]]<br /><applet load="2bc4" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:2bc4.gif|left|200px]]<br /><applet load="2bc4" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="2bc4, resolution 2.270&Aring;" />
caption="2bc4, resolution 2.270&Aring;" />
'''Crystal structure of HLA-DM'''<br />
'''Crystal structure of HLA-DM'''<br />


==Overview==
==Overview==
HLA-DM (DM) plays a critical role in Ag presentation to CD4 T cells by, catalyzing the exchange of peptides bound to MHC class II molecules. Large, lateral surfaces involved in the DM:HLA-DR (DR) interaction have been, defined, but the mechanism of catalysis is not understood. In this study, we describe four small molecules that accelerate DM-catalyzed peptide, exchange. Mechanistic studies demonstrate that these small molecules, substantially enhance the catalytic efficiency of DM, indicating that they, make the transition state of the DM:DR/peptide complex energetically more, favorable. These compounds fall into two functional classes: two compounds, are active only in the presence of DM, and binding data for one show a, direct interaction with DM. The remaining two compounds have partial, activity in the absence of DM, suggesting that they may act at the, interface between DM and DR/peptide. A hydrophobic ridge in the DMbeta1, domain was implicated in the catalysis of peptide exchange because the, activity of three of these enhancers was substantially reduced by point, mutations in this area.
HLA-DM (DM) plays a critical role in Ag presentation to CD4 T cells by catalyzing the exchange of peptides bound to MHC class II molecules. Large lateral surfaces involved in the DM:HLA-DR (DR) interaction have been defined, but the mechanism of catalysis is not understood. In this study, we describe four small molecules that accelerate DM-catalyzed peptide exchange. Mechanistic studies demonstrate that these small molecules substantially enhance the catalytic efficiency of DM, indicating that they make the transition state of the DM:DR/peptide complex energetically more favorable. These compounds fall into two functional classes: two compounds are active only in the presence of DM, and binding data for one show a direct interaction with DM. The remaining two compounds have partial activity in the absence of DM, suggesting that they may act at the interface between DM and DR/peptide. A hydrophobic ridge in the DMbeta1 domain was implicated in the catalysis of peptide exchange because the activity of three of these enhancers was substantially reduced by point mutations in this area.


==About this Structure==
==About this Structure==
2BC4 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CL as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2BC4 OCA].  
2BC4 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CL:'>CL</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BC4 OCA].  


==Reference==
==Reference==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Cuny, G.D.]]
[[Category: Cuny, G D.]]
[[Category: Moradi, B.]]
[[Category: Moradi, B.]]
[[Category: Nicholson, M.J.]]
[[Category: Nicholson, M J.]]
[[Category: Seth, N.P.]]
[[Category: Seth, N P.]]
[[Category: Stein, R.L.]]
[[Category: Stein, R L.]]
[[Category: Wucherpfennig, K.W.]]
[[Category: Wucherpfennig, K W.]]
[[Category: Xing, X.]]
[[Category: Xing, X.]]
[[Category: CL]]
[[Category: CL]]
[[Category: mhc class ii]]
[[Category: mhc class ii]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 08:42:52 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:36:12 2008''

Revision as of 17:36, 21 February 2008

File:2bc4.gif


2bc4, resolution 2.270Å

Drag the structure with the mouse to rotate

Crystal structure of HLA-DM

OverviewOverview

HLA-DM (DM) plays a critical role in Ag presentation to CD4 T cells by catalyzing the exchange of peptides bound to MHC class II molecules. Large lateral surfaces involved in the DM:HLA-DR (DR) interaction have been defined, but the mechanism of catalysis is not understood. In this study, we describe four small molecules that accelerate DM-catalyzed peptide exchange. Mechanistic studies demonstrate that these small molecules substantially enhance the catalytic efficiency of DM, indicating that they make the transition state of the DM:DR/peptide complex energetically more favorable. These compounds fall into two functional classes: two compounds are active only in the presence of DM, and binding data for one show a direct interaction with DM. The remaining two compounds have partial activity in the absence of DM, suggesting that they may act at the interface between DM and DR/peptide. A hydrophobic ridge in the DMbeta1 domain was implicated in the catalysis of peptide exchange because the activity of three of these enhancers was substantially reduced by point mutations in this area.

About this StructureAbout this Structure

2BC4 is a Protein complex structure of sequences from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

ReferenceReference

Small molecules that enhance the catalytic efficiency of HLA-DM., Nicholson MJ, Moradi B, Seth NP, Xing X, Cuny GD, Stein RL, Wucherpfennig KW, J Immunol. 2006 Apr 1;176(7):4208-20. PMID:16547258

Page seeded by OCA on Thu Feb 21 16:36:12 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA